Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan
NCT ID: NCT06852079
Last Updated: 2025-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
119 participants
INTERVENTIONAL
2023-12-23
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A Phase III Safety \& Efficacy Open-label, Single-Arm, Interventional, Multicenter, Study in mild to moderate hypertensive, adults (30 to 60 years of age) prescribed with study product for 12 weeks (84 days).
Primary End Points:
1. Reduction in diastolic blood pressure less than 130 / 80 mmHg at the end of the study period (accepted by WHO) or if there was a fall of 20 / 10 mmHg or more in diastolic blood pressure as compared to baseline.
2. Type, frequency and severity of ADRs during the study period.
Secondary End Points:
1\. Compliance of the prescribed study medication.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diuretic Effect Evaluation of Petroselinum Crispum (Parsley) in Hypertensive Patients
NCT03468361
Effects of Low Salt Diet Versus High Salt Diet on Blood Pressure
NCT00330356
Effectiveness of Viscum Album Mother Tincture as an Anti-hypertensive in Essential Hypertension
NCT01527760
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage
NCT00687206
The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive Patients
NCT02563405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Effect of Qurs e Fishar on Hypertension
Qurs e Fishar
Qurs e Fishar is a herbal remedy for Hypertension
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Qurs e Fishar
Qurs e Fishar is a herbal remedy for Hypertension
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant(s) are willing and able to fulfill the requirements of the study protocol
* Mild to moderate hypertensive
* Mild hypertension range (140-159/90-99 mm Hg)
* Moderate hypertension range (160-179/100-109 mm Hg)
* Be between the age of 30 to 60 year
Exclusion Criteria
* Severe hypertension,
* Congestive cardiac failure,
* Left ventricular failure,
* Myocardial ischemia,
* Renal failure or
* Cerebrovascular accidents
30 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hamdard University
OTHER
Abdul Bari
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdul Bari
Co-Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taj Medical Complex, Hamdard University Hospital
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QF-HLWP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.